tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

HeartSciences Secures New Private Financing Through Note Issuance

Story Highlights
  • On January 13, 2026, HeartSciences raised $3 million via an unsecured promissory note.
  • The 18‑month, 12% note includes strict redemption, penalty and default terms favoring the lender.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
HeartSciences Secures New Private Financing Through Note Issuance

Claim 70% Off TipRanks Premium

Heart Test Laboratories, Inc. ( (HSCS) ) has provided an update.

On January 13, 2026, HeartSciences Inc. entered into a private Note Purchase Agreement with institutional investor Streeterville Capital, LLC, issuing an unsecured promissory note of $3.605 million that includes a $600,000 original issue discount and $5,000 in transaction expense reimbursement, providing the company with $3 million in gross proceeds. The note carries a 12% annual interest rate, matures in 18 months, allows Streeterville to require monthly redemptions up to $405,000 starting six months after issuance, and includes a 5% automatic increase in the outstanding balance if at least $1.25 million has not been repaid by the 12‑month mark, with higher default interest and immediate payment triggers upon certain covenant breaches, underscoring both the company’s need for non‑dilutive financing and the stringent protections secured by the lender.

The most recent analyst rating on (HSCS) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Heart Test Laboratories, Inc. stock, see the HSCS Stock Forecast page.

Spark’s Take on HSCS Stock

According to Spark, TipRanks’ AI Analyst, HSCS is a Neutral.

The score is held down primarily by very weak fundamentals (minimal revenue, large losses, and severe cash burn that increases financing/dilution risk). Technical momentum is comparatively supportive, but it is not enough to offset the financial profile, and valuation is difficult to justify given ongoing losses; the expanded equity incentive plan adds further dilution risk.

To see Spark’s full report on HSCS stock, click here.

More about Heart Test Laboratories, Inc.

HeartSciences Inc. (Heart Test Laboratories, Inc.) operates in the medical technology sector, focusing on cardiovascular diagnostics and related healthcare solutions, with its capital-raising activities aimed at supporting ongoing operations and development within this niche market.

Average Trading Volume: 49,427

Technical Sentiment Signal: Hold

Current Market Cap: $10.04M

For detailed information about HSCS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1